Bardin Hill Management Partners’s Medicines Co MDCO Stock Holding History

Bardin Hill Management Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-415,862	Closed	-$35.3M	–	48
2019 Q4	$35.3M	Buy	+415,862	New	+$27.7M	5.81%	6

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bardin Hill Management Partners's MDCO Position: Q1 2020 in Review

Bardin Hill Management Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 415,862 shares — an estimated $35.3M sold.

Bardin Hill Management Partners first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $35.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Bardin Hill Management Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Bardin Hill Management Partners sold 415,862 Medicines Co shares in Q1 2020, an estimated $35.3M.
Bardin Hill Management Partners first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Bardin Hill Management Partners's Medicines Co position peaked at $35.3M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Bardin Hill Management Partners's 13F filing for Q1 2020, filed 15 May 2020.